Stephen J Evans[Author] - Search Results

Year	Number of Results
2003	2
2004	1
2005	1
2006	2
2007	1
2008	2
2009	3
2010	6
2011	3
2012	7
2013	9
2014	3
2015	4
2016	10
2017	3
2018	2
2019	4
2020	6
2021	12
2022	12
2023	2
2024	4

1

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG; CONSORT Group. Piaggio G, et al. JAMA. 2012 Dec 26;308(24):2594-604. doi: 10.1001/jama.2012.87802. JAMA. 2012. PMID: 23268518

2

Pharmacoepidemiology.

Evans SJ. Evans SJ. Br J Clin Pharmacol. 2012 Jun;73(6):973-8. doi: 10.1111/j.1365-2125.2012.04248.x. Br J Clin Pharmacol. 2012. PMID: 22360737 Free PMC article.

3

Better reporting of harms in randomized trials: an extension of the CONSORT statement.

Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D; CONSORT Group. Ioannidis JP, et al. Ann Intern Med. 2004 Nov 16;141(10):781-8. doi: 10.7326/0003-4819-141-10-200411160-00009. Ann Intern Med. 2004. PMID: 15545678 Free article.

4

The Prevalence of Huntington's Disease.

Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, Smeeth L. Rawlins MD, et al. Neuroepidemiology. 2016;46(2):144-53. doi: 10.1159/000443738. Epub 2016 Jan 30. Neuroepidemiology. 2016. PMID: 26824438 Free article. Review.

5

Safety of medicines delivered by homecare companies.

Matthews A, Donaldson LJ, Evans SJ, Langan SM. Matthews A, et al. Among authors: evans sj. BMJ. 2018 May 22;361:k2201. doi: 10.1136/bmj.k2201. BMJ. 2018. PMID: 29789283 No abstract available.

6

Drug safety and regulation.

Waller PC, Evans SJ, Beard K. Waller PC, et al. BMJ. 2005 Jul 2;331(7507):4-5. doi: 10.1136/bmj.331.7507.4. BMJ. 2005. PMID: 15994664 Free PMC article. No abstract available.

7

Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.

Brown JP, Wing K, Leyrat C, Evans SJ, Mansfield KE, Wong AYS, Smeeth L, Galwey NW, Douglas IJ. Brown JP, et al. Among authors: evans sj. JAMA Cardiol. 2023 Sep 1;8(9):865-870. doi: 10.1001/jamacardio.2023.2418. JAMA Cardiol. 2023. PMID: 37585175

8

Moving along the yellow brick (card) road?

Evans SJ. Evans SJ. Drug Saf. 2013 Oct;36 Suppl 1:S3-4. doi: 10.1007/s40264-013-0096-9. Drug Saf. 2013. PMID: 24166218 No abstract available.

9

In vitro and integrated in vivo strategies to reduce animal use in genotoxicity testing.

Groff K, Evans SJ, Doak SH, Pfuhler S, Corvi R, Saunders S, Stoddart G. Groff K, et al. Among authors: evans sj. Mutagenesis. 2021 Nov 29;36(6):389-400. doi: 10.1093/mutage/geab035. Mutagenesis. 2021. PMID: 34555171 Review.

10

Horizon scanning for novel and emerging in vitro mammalian cell mutagenicity test systems.

Evans SJ, Gollapudi B, Moore MM, Doak SH. Evans SJ, et al. Mutat Res Genet Toxicol Environ Mutagen. 2019 Nov;847:403024. doi: 10.1016/j.mrgentox.2019.02.005. Epub 2019 Feb 21. Mutat Res Genet Toxicol Environ Mutagen. 2019. PMID: 31699342 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year